The Journal of Experimental Medicine · 2004 · 163 citations · 37 references
Life SciencesImmunologyPathobiologyApoptosisAutoimmunityInflammationAutoimmune DiseasesCholesterol MetabolismLipid DisordersLipid-lowering TherapyLipoprotein MetabolismMacrophage BiologyApoptotic Cell Clearance DefectsApoptotic ClearanceApoptotic ResponseAtherosclerosis Molecular MechanismsAtherosclerosis RiskAtherosclerosis-associated MacrophagesAtherosclerotic ProgressionSubclinical Atherosclerosis
To clarify the link between autoimmune disease and hypercholesterolemia, we created the gld.apoE(-/-) mouse as a model of accelerated atherosclerosis. Atherosclerotic lesion area was significantly increased in gld.apoE(-/-) mice compared with apoE(-/-) mice. gld.apoE(-/-) mice also displayed increases in lymphadenopathy, splenomegaly, and autoantibodies compared with gld mice, and these effects were exacerbated by high cholesterol diet. gld.apoE(-/-) mice exhibited higher levels of apoptotic cells, yet a reduced frequency of engulfed apoptotic nuclei within macrophages. Infusion of lysophosphatidylcholine, a component of oxidized low density lipoprotein, markedly decreased apoptotic cell clearance in gld mice, indicating that hypercholesterolemia promotes autoimmune disease in this background. These data suggest that defects in apoptotic cell clearance promote synergy between atherosclerotic and autoimmune diseases.
37
S Manzi, Elaine N. Meilahn, Joan E. Rairie et al. · American Journal of Epidemiology · 1997 · 1.8K citations
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Tomohiro Takahashi, Masato Tanaka, Camllynn I. Brannan et al. · Cell · 1994 · 1.5K citations
Life Sciences, Immunology, Pathology +12
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Frédéric Rieux‐Laucat, Françoise Le Deist, Claire Hivroz et al. · Science · 1995 · 1.3K citations
Life Sciences, Immunology, Pathology +17